Condition 1: newborn affected by noxious influences transmitted via breast milk. Condition 2: Neonatal jaundice. Neonatal jaundice due to drugs or toxins transmitted from mother or given to newborn Neonatal jaundice from breast milk inhibitor
Conditions
Interventions
Intervention 1: Intervention group: Mothers will be received 3 grams of fennel with added ingredients include honey, frankincense and preservatives for 15 days, once daily before breakfast. Interventi
Treatment - Drugs
Placebo
Intervention group: Mothers will be received 3 grams of fennel with added ingredients include honey, frankincense and preservatives for 15 days, once daily before breakfast.
Placebo composition include honey, frankincense and preservatives and mothers for 15 days, once daily before breakfast syrup can be used.
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion Criteria:The mother is healthy and primipara; with normal vaginal delivery; Willingness to participate in the study; Do not use herbal medicines or other chemical drugs; Be at least literacy Reading and writing; No history of allergy to the material studied; Lack of symptoms Hirsute; No history of kidney disease or the mother malignant; Having a healthy and full-term infants.Exclusive breastfeeding: Having a contact number; Absence of the nipple for breastfeeding infants; Residing in Hamadan city. Exclusion Criteria: The incidence of allergy symptoms In the mother or baby to studied substances; The incidence of the disease in the mother or infant; Use of any material increases maternal milk; Infants are feeding with any kind of substances other than the breast-fed; Cancel the parent companies to participatie in the study; Relocate to another city.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Maternal Serum Prolactin. Timepoint: In the first 24 hours after delivery and 15 days after taking the prescribed syrups. Method of measurement: The amount of prolactin in vivo by an ELISA kit and ELISA reader will be measured.;The neonatal Skin Billirubin. Timepoint: On the first day of study before starting treatment and on days 5, 10 and 15 after initiation of treatment. Method of measurement: The skin bilirubin with the Billie test devices will be measured.;Side effect of druge. Timepoint: during of study and the end of study. Method of measurement: with qusetion of mothers. | — |
Countries
Iran (Islamic Republic of)
Outcome results
None listed